| 2024-03-21 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 14,491 0.0266% | $35.31 | $511,677 | -16.66% | |
| 2024-03-20 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 400 0.0007% | $35.31 | $14,124 | -15.85% | |
| 2024-03-19 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 12,364 0.0227% | $35.31 | $436,573 | -16.39% | |
| 2024-03-13 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 62,366 0.1107% | $33.74 | $2.1M | -14.39% | |
| 2024-03-12 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 3,884 0.0071% | $32.99 | $128,133 | -9.79% | |
| 2024-02-26 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 5,000 0.0094% | $30.21 | $151,050 | +1.93% | |
| 2023-01-17 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 4,826 0.0088% | $39.92 | $192,638 | -21.01% | |
| 2023-01-06 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 174 0.0003% | $39.90 | $6,943 | -19.15% | |
| 2022-12-01 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 5,000 0.0094% | $37.48 | $187,416 | -8.72% | |
| 2022-11-11 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 6,800 0.0126% | $34.95 | $237,655 | -0.83% | |
| 2022-11-09 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 700 0.0014% | $34.97 | $24,480 | +6.43% | |
| 2018-06-29 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 8,786 0.0169% | $59.90 | $526,306 | -36.07% | |
| 2018-06-28 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 6,804 0.0135% | $59.94 | $407,798 | -34.41% | |
| 2018-06-21 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 14,410 0.0164% | $34.57 | $498,105 | -33.83% | |
| 2018-05-15 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 7,868 0.0145% | $55.65 | $437,842 | -24.39% | |
| 2018-05-11 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 83,382 0.1223% | $43.46 | $3.62M | -22.3% | |
| 2018-05-10 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 40,000 0.0446% | $28.89 | $1.16M | -11.12% | |
| 2018-01-22 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 20,000 0.0421% | $48.04 | $960,716 | +3.5% | |
| 2018-01-17 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr. VP of IP, CSO | 20,000 0.0375% | $44.98 | $899,500 | -1.51% | |
| 2017-09-08 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Sr VP of IP, CSO | 5,000 0.01% | $49.86 | $249,303 | -8.95% |